XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Long-Term Debt (Tables)
3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
The following is a summary of Organon’s total debt:
($ in millions)March 31, 2025December 31, 2024
Term Loan B Facility:
SOFR plus 225 bps term loan due 2031
$1,543 $1,543 
EURIBOR plus 275 bps euro-denominated term loan due 2031 (€722 million in 2025 and €724 million in 2024)
779 755 
4.125% secured notes due 2028
2,100 2,100 
2.875% euro-denominated secured notes due 2028 (€1.25 billion)
1,348 1,304 
5.125% notes due 2031
2,000 2,000 
6.750% secured notes due 2034
500 500 
7.875% notes due 2034
500 500 
Revenue Interest Purchase and Sale Agreement (1)
169 165 
NovaQuest Funding Agreement (1)
103 103 
Other borrowings
Other (discounts and debt issuance costs)(93)(97)
Total principal long-term debt$8,956 $8,880 
Less: Current portion of long-term debt20 20 
Total Long-term debt, net of current portion$8,936 $8,860 
(1) Recognized at the amortized cost basis. The remaining principal is determined as the initial fair value less principal payments. As of March 31, 2025, the remaining principal of the revenue interest purchase and sale agreement (the “RIPSA”) the Company assumed in connection with its acquisition of Dermavant and the NovaQuest Co-Investment Fund VIII, L.P. (“NovaQuest”) debt is $156 million and $102 million, respectively.
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
Long-term debt was recorded at the carrying amount. The estimated fair value of long-term debt (including current portion) is as follows:
($ in millions)Fair Value Measurement LevelMarch 31, 2025December 31, 2024
Long-term debt
2$8,273 $8,354 
Long-term debt (RIPSA & NovaQuest)3272 268 
Schedule of Maturities on Long-term Debt
The schedule of principal payments required on long-term debt for the next five years, exclusive of $14 million of accrued interest related to the RIPSA and NovaQuest debt, and thereafter are as follows:
($ in millions)
2025$
202625 
202762 
20283,490 
2029
Thereafter5,443